Wave Life Sciences Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $4.6600
- Today's High:
- $5.0000
- Open Price:
- $4.7500
- 52W Low:
- $1.16
- 52W High:
- $5.31
- Prev. Close:
- $4.8100
- Volume:
- 136683
Company Statistics
- Market Cap.:
- $0.405 billion
- Book Value:
- 0.357
- Revenue TTM:
- $0.040 billion
- Operating Margin TTM:
- -307.5%
- Gross Profit TTM:
- $-0.074 billion
- Gross Profit TTM:
- $-0.074 billion
- Profit Margin:
- -298%
- Return on Assets TTM:
- -36.9%
- Return on Equity TTM:
- -350.5%
Company Profile
Wave Life Sciences Ltd had its IPO on 2015-11-11 under the ticker symbol WVE.
The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Wave Life Sciences Ltd has a staff strength of 0 employees.
Stock update
Shares of Wave Life Sciences Ltd opened at $4.75 at the start of the last trading session i.e. 2022-11-02.
The stocks traded within a range of $4.66 - $5, and closed at $4.84.
This is a +0.62% increase from the previous day's closing price.
A total volume of 136,683 shares were traded at the close of the day’s session.
In the last one week, shares of Wave Life Sciences Ltd have slipped by -3.2%.
Wave Life Sciences Ltd's Key Ratios
Wave Life Sciences Ltd has a market cap of $0.405 billion, indicating a price to book ratio of 12.68 and a price to sales ratio of 10.04.
In the last 12-months Wave Life Sciences Ltd’s revenue was $0.040 billion with a gross profit of $-0.074 billion and an EBITDA of $-0.117 billion. The EBITDA ratio measures Wave Life Sciences Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Wave Life Sciences Ltd’s operating margin was -307.5% while its return on assets stood at -36.9% with a return of equity of -350.5%.
In Q2, Wave Life Sciences Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 86.5%.
Wave Life Sciences Ltd’s PE and PEG Ratio
- Forward PE
- -
- Trailing PE
- -
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-2.151 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Wave Life Sciences Ltd’s profitability.
Wave Life Sciences Ltd stock is trading at a EV to sales ratio of 7.04 and a EV to EBITDA ratio of -2.489. Its price to sales ratio in the trailing 12-months stood at 10.04.
Wave Life Sciences Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0.000 billion
- Total Liabilities
- $0.000 billion
- Operating Cash Flow
- $0.000 billion
- Capital Expenditure
- $0.000 billion
- Dividend Payout Ratio
- 0%
Wave Life Sciences Ltd ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.
Wave Life Sciences Ltd ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.
Wave Life Sciences Ltd’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.
In 1970, Wave Life Sciences Ltd's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.
Comparatively, Wave Life Sciences Ltd paid $0 billion in dividends in 1970.
Other key metrics
- Current Trading Price
- $4.84
- 52-Week High
- $5.31
- 52-Week Low
- $1.16
- Analyst Target Price
- $8.29
Wave Life Sciences Ltd stock is currently trading at $4.84 per share. It touched a 52-week high of $5.31 and a 52-week low of $5.31. Analysts tracking the stock have a 12-month average target price of $8.29.
Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Wave Life Sciences Ltd
Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)
Most Active
Top Gainers
Top Losers
About
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes and produces new stereopure oligonucleotides through PRISM, a drug discovery and development platform. The company is headquartered in Singapore.